Consortium Network

M2Gen’s current Consortium Network includes 18 hospitals and major cancer clinics. These institutions collect tumor specimens and clinical data on thousands of patients who have consented to participate in Moffitt’s Total Cancer Care™ study.

As M2Gen’s Hospital Consortium Network expands, the number of participating institutions and patients served nationwide will increase exponentially. This will provide our biopharmaceutical clients with access to a much larger, more diverse, and robust geographical representation of patients. It will ensure that participating institutions gain two-way scientific and commercial benefits from being part of Moffitt’s Total Cancer Care initiative. And best of all, cancer patients will begin receiving more targeted and effective treatment sooner.

Please contact us for more information.